Thermostable glucocerebrosidase

A plant-derived glucocerebrosidase with thermostability addresses the high cost and frequent administration issues of existing enzyme treatments for Gaucher disease, offering a cost-effective solution for both medical and cosmetic uses by efficiently converting glucosylceramide into ceramide.

JP7583426B2Active Publication Date: 2024-11-14TEIKYO UNIVERSITY
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
JP2020088950
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2020-05-21
Publication Date
2024-11-14
Estimated Expiration
2040-05-21

AI Technical Summary

Technical Problem

Current enzyme preparations for Gaucher disease, such as imiglucerase, are expensive and have low thermostability, requiring frequent administration, and the production of ceramide using animal-derived glucocerebrosidases is costly due to low thermal stability and low natural abundance.

Method used

Development of a plant-derived glucocerebrosidase belonging to glycoside hydrolase family 1 (GH1) with thermostability, which can be produced in plants, animals, or microorganisms, and used to convert glucosylceramide into ceramide, reducing production costs and extending the administration interval.

Benefits of technology

The plant-derived glucocerebrosidase provides a cost-effective and stable enzyme for treating Gaucher disease, allowing less frequent dosing and enabling the production of ceramide for cosmetic and pharmaceutical applications at lower costs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007583426000011
    Figure 0007583426000011
  • Figure 0007583426000012
    Figure 0007583426000012
  • Figure 0007583426000013
    Figure 0007583426000013
Patent Text Reader

Abstract

To provide a protein having glucocerebrosidase activity and also having thermostability.SOLUTION: The aforementioned problem is solved by a protein that is plant-derived, belongs to the glycoside hydrolase family 1 (GH1), and has glucocerebrosidase activity.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a protein having glucocerebrosidase activity and thermostability (hereinafter, this may be referred to as "thermostable glucocerebrosidase"), an enzyme composition, a pharmaceutical composition or a food composition containing this protein, a method for producing ceramide using this protein, and the like. [Background technology]

[0002] Glucocerebrosidase is known as an enzyme that hydrolyzes glucosylceramide, a type of glycolipid, to convert it into ceramide. Glucocerebrosidase is known to exist mainly in animals and plays an important role in producing ceramide from glucosylceramide in the animal body, but its existence in plants is hardly known.

[0003] In humans, there is a congenital metabolic disorder (Gaucher disease) in which the glucocerebrosidase gene is congenitally deficient and the body is unable to convert glucosylceramide to ceramide. In Gaucher disease, glucosylceramide accumulates abnormally in the body, resulting in various symptoms such as enlargement of the liver and spleen, anemia, decreased platelets, and bone abnormalities (Non-Patent Documents 1 and 2).

[0004] It is said that there are more than 5,000 Gaucher disease patients worldwide, and the main treatment involves replenishing the body's deficient glucocerebrosidase through intravenous infusion, thereby converting the accumulated glucosylceramide into ceramide. [Prior art documents] [Non-patent literature]

[0005] [Non-Patent Document 1] Annual Review of Genomics and Human Genetics 4,403-436 (2003) [Non-Patent Document 2] British Journal of Haematology 129,178-188 (2005) Summary of the Invention [Problem to be solved by the invention]

[0006] Currently, the enzyme preparations used as intravenous drugs for Gaucher disease mainly use imiglucerase, which is a human-derived glucocerebrosidase produced in Chinese hamster ovary cells using genetic engineering technology. However, this imiglucerase is expensive and has low thermal stability, so it needs to be replenished once every two weeks, which is a major economic burden for patients.

[0007] In addition, since glucocerebrosidase derived from animals is an enzyme that acts at about the body temperature of the animal, it has low heat stability like the above-mentioned imiglucerase. Therefore, if there is a glucocerebrosidase that is heat stable and requires less frequent supplementation, its medical value would be immeasurable, but there has been no report of such a glucocerebrosidase yet.

[0008] On the other hand, ceramide, which exists in the keratin of human skin, is a necessary ingredient for keeping skin moisturized, and is incorporated in cosmetics, etc., but the ceramide as an active ingredient of cosmetics, etc. is usually produced by chemical synthesis.Here, it is considered that glucosylceramide, which is high in content in animals and plants and is relatively inexpensive, is decomposed by glucocerebrosidase to produce ceramide, and this ceramide is used in cosmetics, reagents, etc., but the above-mentioned imiglucerase is very expensive and has low thermal stability, so it has not been put into practical use.In addition, the ceramide content in animals and plants is very low, unlike glucosylceramide, so if this ceramide is directly extracted and purified, it will cost a huge amount of money.

[0009] Therefore, an object of the present invention is to provide a protein which has glucocerebrosidase activity and further has thermostable activity. [Means for solving the problem]

[0010] In order to solve the above problems, the present inventors have conducted extensive research and found a protein derived from a plant, belonging to glycoside hydrolase family 1, and having glucocerebrosidase activity. They also found that this protein has thermostability, and thus completed the present invention. However, there have been no reports to date that a glucocerebrosidase belonging to GH1 has been found in a plant.

[0011] That is, the present invention provides the following <1> ~ <17> It is. <1> A protein derived from plants, belonging to the glycoside hydrolase family 1, and having glucocerebrosidase activity. <2> The plant is a seed plant. <1> The protein according to claim 1. <3> The seed plant is any one of a Brassicaceae plant, a Gramineae plant, a Cucurbitaceae plant, a Asteraceae plant, a Solanaceae plant, a Rosaceae plant, an Amaryllidaceae plant, a Leguminosae plant, and a Liliaceae plant. <2> The protein according to claim 1. <4> A protein shown in (A), (B), or (C) below. (A) A protein consisting of the amino acid sequence shown in SEQ ID NO:1, amino acid numbers 38 to 521 of SEQ ID NO:1, SEQ ID NO:2, or amino acid numbers 19 to 503 of SEQ ID NO:2 in the sequence listing. (B) A protein consisting of an amino acid sequence in which one or several amino acids have been substituted, deleted, inserted, or added in the amino acid sequence shown in SEQ ID NO: 1, amino acid numbers 38 to 521 of SEQ ID NO: 1, SEQ ID NO: 2, or amino acid numbers 19 to 503 of SEQ ID NO: 2 in the sequence listing, which belongs to glycoside hydrolase family 1 and has glucocerebrosidase activity and thermal stability. (C) A protein having 60% or more homology to the amino acid sequence shown in SEQ ID NO:1, amino acid numbers 38 to 521 of SEQ ID NO:1, SEQ ID NO:2, or amino acid numbers 19 to 503 of SEQ ID NO:2 in the sequence listing, belonging to glycoside hydrolase family 1, and having glucocerebrosidase activity and thermal stability. <5> <1> ~ <4> A DNA encoding any one of the proteins described above. <6> DNA shown in (a), (b), or (c) below. (a) A DNA encoding a protein belonging to glycoside hydrolase family 1 and having glucocerebrosidase activity, the DNA consisting of the base sequence shown in SEQ ID NO: 3, base numbers 112 to 1566 of SEQ ID NO: 3, SEQ ID NO: 4, or base numbers 55 to 1512 of SEQ ID NO: 4 in the sequence listing. (b) A DNA consisting of a base sequence in which one or several bases have been substituted, deleted, inserted, or added in the base sequence shown in SEQ ID NO: 3, base numbers 112 to 1566 of SEQ ID NO: 3, SEQ ID NO: 4, or base numbers 55 to 1512 of SEQ ID NO: 4 in the sequence listing, and which belongs to glycoside hydrolase family 1 and encodes a protein having glucocerebrosidase activity and thermal stability. (c) A DNA capable of hybridizing under stringent conditions with a DNA consisting of a base sequence complementary to the base sequence shown in SEQ ID NO: 3, base numbers 112 to 1566 of SEQ ID NO: 3, SEQ ID NO: 4, or base numbers 55 to 1512 of SEQ ID NO: 4 in the sequence listing, which belongs to glycoside hydrolase family 1 and encodes a protein having glucocerebrosidase activity and thermal stability. <7> <5> or <6> An expression vector for expressing a protein belonging to glycoside hydrolase family 1 and having glucocerebrosidase activity and thermostability, comprising the DNA described in <8> <7> A transformant into which the expression vector described in is introduced. <9> The transformant is any one of a plant body, a plant cell, an animal cell, Escherichia coli, a yeast, and a filamentous fungus. <8> A transformant according to claim 1. <10> <8> or <9> and culturing the transformant according to claim 1, and producing a transformant or a material containing the transformant obtained by this step. <1> ~ <4> and recovering the protein according to any one of the above items. <11> <1> ~ <4> 13. A glucosylceramide hydrolase composition comprising the protein according to any one of claims 1 to 12. <12> <1> ~ <4> A pharmaceutical composition comprising the protein according to any one of the above items as an active ingredient. <13> For preventing and treating Gaucher disease, <12> The pharmaceutical composition described in <14> <1> ~ <4> 1. A food composition comprising the protein according to any one of claims 1 to 9 and glucosylceramide isolated from a plant, animal, or microorganism, or chemically synthesized glucosylceramide. <15> <1> ~ <4> 2. A method for producing ceramide, comprising the step of producing ceramide from glucosylceramide isolated from a plant, animal, or microorganism, or from chemically synthesized glucosylceramide, using the protein according to any one of claims 1 to 11.

[0012] <16> <1> ~ <4> or <12> or <13> A method for preventing or treating Gaucher disease, comprising administering (by intravenous infusion or the like) the pharmaceutical composition described in claim 1 to a patient with Gaucher disease. <17> The protein or the pharmaceutical composition is administered to a patient with Gaucher disease once every 3 to 10 weeks so that the glucocerebrosidase activity is 10 to 200 U / kg of body weight. <16> The method for preventing or treating Gaucher disease described in claim 1. Effect of the Invention

[0013] According to the present invention, it is possible to provide a protein which belongs to glycoside hydrolase family 1 and has glucocerebrosidase activity and thermostability. It is also possible to provide an enzyme composition, a pharmaceutical composition, and a food composition which contain this protein, and further to provide a method for producing ceramide using this protein. [Brief description of the drawings]

[0014] [Figure 1] 1 is a graph showing the relationship between incubation time at 37° C. (pH 5) and relative residual activity for rice-derived glucocerebrosidase (RGC1) and human-derived glucocerebrosidase (imiglucerase). [Diagram 2] 1 is a graph showing the relationship between incubation time at 37° C. (pH 7) and relative residual activity for rice-derived glucocerebrosidase (RGC1) and human-derived glucocerebrosidase (imiglucerase). [Diagram 3] 1 is a graph showing the relationship between incubation time at 45° C. (pH 5) and relative residual activity of soybean-derived glucocerebrosidase (SGC1) and human-derived glucocerebrosidase (imiglucerase). [Figure 4] 1 is a graph showing the relationship between incubation time at 45° C. (pH 7) and relative residual activity of soybean-derived glucocerebrosidase (SGC1) and human-derived glucocerebrosidase (imiglucerase). [Diagram 5] 1 is the amino acid sequence of rice glucocerebrosidase (RGC1). [Figure 6] This is the base sequence of the DNA encoding rice-derived glucocerebrosidase (RGC1). [Figure 7] This shows the amino acid sequences of nine peptide fragments obtained by trypsin treatment of rice-derived glucocerebrosidase (RGC1). [Figure 8] 1 shows the nucleotide sequences of the F-primer and R-primer used in cloning the DNA encoding rice glucocerebrosidase (RGC1). [Figure 9] 1 is the amino acid sequence of soybean glucocerebrosidase (SGC1). [Figure 10] This is the base sequence of the DNA encoding soybean-derived glucocerebrosidase (SGC1). [Figure 11]1 shows the amino acid sequences of seven peptide fragments obtained by trypsin treatment of soybean glucocerebrosidase (SGC1). [Figure 12] 1 shows the nucleotide sequences of the F-primer and R-primer used in cloning the DNA encoding soybean glucocerebrosidase (SGC1). DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0015] The present invention will now be described. The present invention relates to a protein that is derived from a plant, belongs to glycoside hydrolase family 1, and has glucocerebrosidase activity (hereinafter, this will also be referred to as the "protein of the present invention" or the "thermostable glucocerebrosidase of the present invention"), DNA encoding the protein of the present invention and an expression vector containing this DNA, a transformant into which this expression vector has been introduced and a method for producing the protein of the present invention using this transformant, an enzyme composition, a pharmaceutical composition or a food composition containing the protein of the present invention, a method for producing ceramide using the protein of the present invention, etc.

[0016] First, the protein of the present invention will be described in detail. The protein of the present invention is derived from a plant, belongs to glycoside hydrolase family 1 (GH1), and has glucocerebrosidase activity. This plant-derived GH1 protein having glucocerebrosidase activity is thermostable.

[0017] Here, "glucocerebrosidase activity" refers to the enzyme activity of an enzyme (glucocerebrosidase) with the EC number (EC3.2.1.45), that is, the activity of catalyzing the reaction of hydrolyzing the β-1,4-glycosyl bond between glucose and ceramide in glucosylceramide, a glycolipid, to produce ceramide. In addition, "glycoside hydrolase family 1" is one of the families of carbohydrate hydrolases classified into about 130 by the Carbohydrate Active enzyme database (CAZy database, http: / / www.cazy.org / ), and glucocerebrosidases that belong to glycoside hydrolase family 1 (GH1), glycoside hydrolase family 30 (GH30), and glycoside hydrolase family 116 (GH116) are known.

[0018] Additionally, "plant-derived" means that the protein is expressed from a plant gene, and the plant gene can be obtained, for example, from at least one selected from the group consisting of plant leaves, stems, roots, seeds, fruits, petals, pistils, pollen (stamens), rhizoids, and sporangia. Furthermore, "thermostable" means a performance in which, in a solution containing a protein having glucocerebrosidase activity so as to have a glucocerebrosidase activity of 0.0002 to 0.0008 U / mL in 50 mM acetate buffer (pH 5.0) containing 0.1% Triton X-100 (registered trademark, the same applies below) and 0.05% sodium cholate, the glucocerebrosidase activity remains at 80% or more when incubated at 37°C for 30 hours (relative residual activity is 80% or more when the glucocerebrosidase activity before this incubation is taken as 100%). It is preferable that the above-mentioned relative residual activity of this thermostability is 90% or more. Here, this glucocerebrosidase activity is measured as follows. Specifically, a given amount of sample was added to 50 mM acetate buffer (pH 5.5) containing 100 μM glucosylceramide (cerebroside B, (4E,8E)-ND-2'-hydroxypalmitoyl-1-O-β-D-glucopyranosyl-9-methyl-4,8-sphingadienine ("E", "N" and "O" are italics, and "D" is small capital letters): The Journal of Antibiotics 41, (1988) 469-480, the same below), 0.1% Tween 20 and 0.05% sodium cholate, and incubated at 37°C for 15 to 60 minutes. Next, a four-fold amount of ethanol was added to the resulting enzyme reaction solution, mixed, and centrifuged at 15,000 rpm for 20 minutes. The supernatant was subjected to high-performance liquid chromatography analysis to measure the amount of ceramide produced by the enzyme reaction. Other conditions required for measuring glucocerebrosidase activity are as described in Example 2 below.

[0019] The protein of the present invention is preferably derived from a seed plant. Examples of seed plants include, but are not limited to, plants of the family Malvaceae, family Chenopodiaceae, family Rubiaceae, family Cannabaceae, family Hydrangeaceae, family Cruciferae, family Iridaceae, family Poaceae, family Araliaceae, family Cucurbitaceae, family Anacardiaceae, family Cyperaceae, family Campanulaceae, family Asteraceae, family Lauraceae, family Mulberry, family Papaveraceae, family Araceae, family Cactaceae, family Lamiaceae, family Nymphaeaceae, family Apiaceae, family Polygonaceae, family Ericaceae, Specific examples include plants of the family Theaceae, Solanaceae, Caryophyllaceae, Ulmaceae, Nelumbaceae, Rosaceae, Nelumbaceae, Amaryllidaceae, Convolvulaceae, Vitaceae, Fagaceae, Paeoniaceae, Legumes, Rutaceae, Pontederiaceae, Oleaceae, Palmaceae, Salicaceae, Liliaceae, Orchidaceae, Yews, Ginkgoaceae, Pinaceae, Cycadaceae, Cupressaceae, and Pinaceae.

[0020] More specific examples of seed plants include cotton, hibiscus, spinach, goosefoot, beet, madder, gardenia, coffee tree, hemp, hops, hydrangea, thailand purse, rapeseed, radish, Chinese cabbage, cabbage, cauliflower, broccoli, komatsuna, bok choy, wasabi, iris, Japanese iris, iris, rice, timothy, wheat, corn, sorghum, barley, rye, sugar cane, oats, barnyard millet, foxtail millet, lawn grass, reed, bamboo, bamboo grass, and bamboo grass. Ranoki, Udo, Fatsia, cucumber, bitter melon, melon, watermelon, bitter melon, pumpkin, loofah, squash, gourd, bottle gourd, snow gourd, sumac, wax tree, star grass, bellflower, golden daisy, lettuce, gerbera, gazania, thistle, burdock, sunflower, cosmos, dandelion, calendula, butterbur, ragweed, camphor tree, bay laurel, mulberry, fig, corn poppy, watercress, taro, cactus, perilla, salvia, lavender, water lily, carrot, parsley, sedge Loli, buckwheat, knotweed, azalea, blueberry, rhododendron, camellia, tomato, eggplant, tobacco, petunia, chili pepper, potato, dianthus, carnation, baby's breath, chickweed, zelkova, Zelkova, lotus, rose, cherry blossom, almond, apricot, strawberry, plum, apple, pear, loquat, peach, lotus, garlic, leek, onion, bindweed, morning glory, sweet potato, grape, beech, oak, sawtooth oak, chestnut, peony, soybean, broad bean, black bean, wisteria, Japanese wisteria, lupin The following trees are shown: eggplant, kidney bean, pea, alfalfa, peanut, sweet pea, lotus grass, satsuma mandarin, pepper, natsudaikan, orange, lime, lemon, grapefruit, trifoliate orange, water hyacinth, olive, jasmine, coconut, oil palm, date palm, palm, poplar, willow, lily, lily, tulip, daffodil, moth orchid, cattleya, vanilla, yew, Japanese iris, ginkgo, cedar, cycad, cypress, and pine.

[0021] Among these, proteins belonging to GH1 derived from any of the Brassicaceae, Gramineae, Cucurbitaceae, Asteraceae, Solanaceae, Rosaceae, Amaryllidaceae, Legumes, or Liliaceae families and having glucocerebrosidase activity are particularly preferred because of their excellent thermal stability. For example, proteins belonging to GH1 derived from rice or soybean and having glucocerebrosidase activity are extremely preferred in terms of both their glucocerebrosidase activity and thermal stability.

[0022] The thermostable glucocerebrosidase of the present invention, which is derived from rice, consists of the amino acid sequence shown in SEQ ID NO: 1 in the sequence listing, or the amino acid sequence of SEQ ID NO: 1 from which the signal peptide has been cleaved, which is the amino acid sequence of amino acid numbers 38 to 521. The thermostable glucocerebrosidase of the present invention, which is derived from soybean, consists of the amino acid sequence shown in SEQ ID NO: 2 in the sequence listing, or the amino acid sequence of SEQ ID NO: 2 from which the signal peptide has been cleaved, which is the amino acid sequence of amino acid numbers 19 to 503.

[0023] The present invention also includes a protein that is composed of an amino acid sequence in which one or several amino acids are substituted, deleted, inserted, or added in any of the amino acid sequences shown in SEQ ID NO: 1 in the sequence listing, amino acid numbers 38 to 521 in SEQ ID NO: 1, SEQ ID NO: 2 in the sequence listing, or amino acid numbers 19 to 503 in SEQ ID NO: 2, belongs to GH1, and has glucocerebrosidase activity and thermostability. In this case, the protein is preferably derived from a plant, but may not be derived from a plant (the "protein of the present invention" described later may also include proteins that are not derived from a plant). Here, "several" means 10 or less, preferably 6 or less, and more preferably 5 or less.

[0024] The substitution, deletion, insertion, or addition of the amino acid is conservative. In other words, it means that one or several amino acid residues are substituted, deleted, inserted, or added so as not to substantially change the properties of the protein. For example, a hydrophobic amino acid residue is substituted with another hydrophobic amino acid residue, a polar amino acid residue is substituted with another polar amino acid residue having the same charge, and the like. Specific examples of such functionally similar amino acids include hydrophobic (non-polar) amino acids such as alanine, valine, isoleucine, leucine, proline, tryptophan, phenylalanine, and methionine. Among the polar amino acids, neutral amino acids include glycine, serine, threonine, tyrosine, glutamine, asparagine, and cysteine. Examples of basic amino acids include arginine, histidine, and lysine. Examples of acidic amino acids include aspartic acid and glutamic acid.

[0025] Furthermore, the present invention also includes a protein having a homology of 60% or more, more preferably 62% or more, more preferably 65% ​​or more, more preferably 67% or more, more preferably 70% or more, more preferably 73% or more, more preferably 77% or more to any of the amino acid sequences shown in SEQ ID NO: 1, amino acid numbers 38 to 521 in SEQ ID NO: 1, or amino acid numbers 19 to 503 in SEQ ID NO: 2 in the sequence listing, belonging to GH1, and having glucocerebrosidase activity and thermostability. In this case, the protein is preferably derived from a plant, but may not be derived from a plant. Here, the "homology" is a numerical value calculated using default (initial setting) parameters in the homology search program EMBOSS Needle (https: / / www.ebi.ac.uk / Tools / psa / emboss_needle / ).

[0026] Next, the DNA encoding the protein of the present invention and the method for producing the protein using this DNA will be described in detail.

[0027] The DNA encoding the protein of the present invention is not limited, and may be naturally derived or synthesized using a part of naturally derived DNA, as long as it is composed of a base sequence capable of expressing the protein. For example, the DNA encoding the thermostable glucocerebrosidase of the present invention derived from rice is SEQ ID NO: 3 in the sequence listing, or the DNA consisting of the base sequence shown in SEQ ID NO: 3 from base numbers 112 to 1566. The DNA encoding the thermostable glucocerebrosidase of the present invention derived from soybean is SEQ ID NO: 4 in the sequence listing, or the DNA consisting of the base sequence shown in SEQ ID NO: 4 from base numbers 55 to 1512.

[0028] Further examples include DNAs consisting of a base sequence in which one or several bases have been substituted, deleted, inserted or added in any of the base sequences shown in SEQ ID NO: 3, base numbers 112 to 1566 in SEQ ID NO: 3, SEQ ID NO: 4, or base numbers 55 to 1512 in SEQ ID NO: 4 in the sequence listing, and which encode a protein belonging to GH1 and having glucocerebrosidase activity and thermostability. Here, "several" means 20 or less, preferably 10 or less, and more preferably 6 or less.

[0029] Further examples include DNA that can hybridize under stringent conditions with DNA consisting of a base sequence complementary to any of the base sequences shown in SEQ ID NO: 3, base numbers 112 to 1566 of SEQ ID NO: 3, SEQ ID NO: 4, or base numbers 55 to 1512 of SEQ ID NO: 4 in the sequence listing, and that encodes a protein belonging to GH1 and having glucocerebrosidase activity and thermostability. Here, "stringent conditions" refer to conditions under which so-called specific hybrids are formed and non-specific hybrids are not formed. For example, hybridization is performed at 65°C in the presence of 0.7 to 1.0 M sodium chloride, followed by washing 1 to 3 times at 60°C, preferably 65°C, more preferably 68°C using 0.1 to 5×SSC, 0.1% SDS solution (1×SSC composition: 150 mM sodium chloride, 15 mM sodium citrate).

[0030] In the present invention, an expression vector is also provided that can be replicated in a host plant, plant cell, animal cell (including insect cell), or microorganism, and contains the above-mentioned DNA in a state in which the protein encoded by the DNA can be expressed. That is, an expression vector for expressing a protein belonging to GH1 and having glucocerebrosidase activity and thermostability is also provided. This expression vector can be constructed using, for example, a self-replicating vector that exists as an independent entity outside the chromosome of the host cell and whose replication does not depend on the replication of chromosomal DNA, or a vector that is incorporated into the chromosomal DNA of the host cell and replicates together with the chromosomal DNA, and a plasmid vector or a virus vector is shown as a preferred example. The procedure and method for constructing the expression vector can be a method commonly used in the field of genetic engineering.

[0031] In order to express the protein of the present invention in a transformant into which the expression vector is actually introduced, the expression vector preferably contains, in addition to the DNA encoding the protein of the present invention, a base sequence for controlling the expression and a genetic marker for selecting the transformant. Examples of the base sequence for controlling the expression include a promoter, a terminator, and a base sequence encoding a signal peptide other than those described above. The promoter is not particularly limited as long as it exhibits transcription activity in the host. The signal peptide is also not particularly limited as long as it contributes to the extracellular secretion of the protein in the host. The genetic marker may be appropriately selected depending on the method for selecting the transformant, and for example, a drug resistance gene, a gene complementing auxotrophy, etc. can be used.

[0032] Furthermore, the present invention also provides a transformant in which the above-mentioned expression vector is introduced into the cells and / or chromosomal DNA of a host. The host-vector system is not particularly limited, and for example, a system using a plant body, a plant cell, an animal cell, or a microorganism (E. coli, yeast, filamentous fungus, etc.), or a fusion protein expression system using them with other proteins, etc. can be used. Furthermore, the introduction of the above-mentioned expression vector into a host, that is, the transformation of a host using the above-mentioned expression vector, can be carried out according to a method commonly used in this field. Here, as the host to be transformed, it is preferable to use any of a plant body, a plant cell, an animal cell, E. coli, yeast, or a filamentous fungus. In other words, it is preferable to use a transformant of any of a plant body, a plant cell, an animal cell, E. coli, yeast, or a filamentous fungus into which the above-mentioned expression vector is introduced. For example, the protein of the present invention can be expressed in large amounts in a plant body, a plant cell, or an E. coli transformant into which the above-mentioned expression vector is introduced.

[0033] Then, this transformant is bred or cultured under conditions that allow the transformant to grow and proliferate while maintaining its characteristics, and the protein of the present invention can be recovered from the obtained transformant (plant body, cultured plant cells, cultured animal cells, etc.) or its contents (culture solution or solid medium containing cultured cells, etc.). Therefore, the present invention provides a method for producing the protein of the present invention, which includes a step of breeding or culturing this transformant, and a step of recovering (crude or purified) the protein of the present invention from the transformant obtained by this step or its contents. The breeding and culture methods and conditions of the transformant may be any methods and conditions that allow the transformant to grow and proliferate while maintaining its characteristics, and are not particularly limited, but may be substantially equivalent to the breeding or culture methods and conditions for the plant body, plant cells, animal cells, or microorganisms used as hosts. In addition, after breeding or culturing the transformant, the target protein can also be recovered by a crude method or purification method commonly used in this field.

[0034] A preferred embodiment of the method for producing the protein of the present invention is a method using a plant body, a plant cell, or a transformant of an animal cell. Examples of animal cells include Chinese hamsters and humans. Examples of plant bodies and plant cells include Malvaceae, Chenopodiaceae, Rubiaceae, Cannabaceae, Hydrangeaceae, Brassicaceae, Iridaceae, Gramineae, Araliaceae, Cucurbitaceae, Anacardiaceae, Cyperaceae, Campanulaceae, Asteraceae, Lauraceae, Mulberry, Papaveraceae, Araceae, Cactaceae, Lamiaceae, Nymphaeaceae, Umbelliferae, Polygonaceae, Ericaceae, Tuba Examples of plants that may be included in the plant family include plants of the family Cassia, Solanaceae, plants of the family Caryophyllaceae, plants of the family Ulmaceae, plants of the family Nelumbaceae, plants of the family Rosaceae, plants of the family Nelumbaceae, plants of the family Amaryllidaceae, plants of the family Convolvulaceae, plants of the family Vitaceae, plants of the family Fagaceae, plants of the family Paeoniaceae, plants of the family Fabaceae, plants of the family Rutaceae, plants of the family Pontederiaceae, plants of the family Oleaceae, plants of the family Palmaceae, plants of the family Salicaceae, plants of the family Liliaceae, plants of the family Orchidaceae, plants of the family Yew, plants of the family Ginkgo, plants of the family Cycadaceae, plants of the family Cupressaceae, and plants of the family Pinaceae.More specifically, cotton, hibiscus, spinach, goosefoot, beet, madder root, gardenia, coffee tree, hemp, hops, hydrangea, white shepherd's purse, rapeseed, radish, Chinese cabbage, cabbage, cauliflower, broccoli, komatsuna, bok choy, wasabi, iris, Japanese iris, iris, rice, timothy, wheat, corn, sorghum, barley, rye, sugar cane, oats, barnyard millet, foxtail millet, lawn grass, reed, bamboo, bamboo grass, elm, udo, Fatsia, cucumber, bitter melon, melon, watermelon, bitter melon, pumpkin, loofah, squash, gourd, bottle gourd, sumac, wax tree, star grass, bellflower, golden daisy, lettuce, gerbera, gazania, thistle, burdock, sunflower, cosmos, dandelion, calendula, butterbur, ragweed, camphor tree, bay laurel, mulberry, fig, corn poppy, duckweed, taro, cactus, perilla, salvia, lavender, water lily, carrot, parsley, celery, buckwheat , knotweed, azalea, blueberry, rhododendron, camellia, tomato, eggplant, tobacco, petunia, chili pepper, potato, dianthus, carnation, baby's breath, chickweed, zelkova, Zelkova, lotus, rose, cherry blossom, almond, apricot, strawberry, plum, apple, pear, loquat, peach, lotus, garlic, leek, onion, bindweed, morning glory, sweet potato, grape, beech, oak, sawtooth oak, chestnut, peony, soybean, broad bean, black bean, wisteria, Japanese wisteria, lupine, These include kidney beans, peas, alfalfa, peanuts, sweet peas, lotus grass, satsuma mandarins, pepper, natsudaidai, oranges, limes, lemons, grapefruit, trifoliate orange, water hyacinth, olives, jasmine, coconut palm, oil palm, date palm, palm, poplar, willow, lilies, lilies, tulips, daffodils, moth orchids, cattleya, vanilla, yew, Japanese iris, ginkgo, cedar, cycad, cypress, and pine.

[0035] Another preferred embodiment of the method for producing the protein of the present invention is a method using a transformant of Escherichia coli cells, yeast cells, or filamentous fungal cells. Examples of yeast cells include microorganisms belonging to the genera Saccharomyces, Hansenula, or Pichia, such as Saccharomyces cerevisiae. Examples of filamentous fungal cells include those belonging to the genera Humicola, Trichoderma, Staphylotrichum, Aspergillus, Fusarium, or Acremonium (all scientific names in parentheses are italicized).

[0036] Next, the enzyme composition, pharmaceutical composition, food composition, etc., which contain the protein of the present invention will be described in detail.

[0037] The present invention can provide an enzyme composition containing the above-mentioned protein of the present invention. This enzyme composition contains the protein of the present invention as an active ingredient (the active ingredient of the glucocerebrosidase activity of the enzyme composition) and can be suitably used for hydrolyzing glucosylceramide (for hydrolyzing glucose in glucosylceramide molecules), that is, for converting glucosylceramide to ceramide.

[0038] Furthermore, by incorporating the protein of the present invention as an active ingredient, a pharmaceutical composition can be provided. This pharmaceutical composition can be suitably used for the prevention and treatment of Gaucher disease. The pharmaceutical composition is preferably in the form of an infusion drug, but may also be in the form of an oral drug (tablet, powder, syrup, etc.).

[0039] In other words, the present invention can provide a method for preventing or treating Gaucher disease, in which a pharmaceutical composition containing the protein of the present invention as an active ingredient is administered (for example, by infusion) to a patient with Gaucher disease. As for the dosage and administration method, it is preferable to administer the protein of the present invention or a pharmaceutical composition containing the protein of the present invention as an active ingredient (a preventive and therapeutic agent for Gaucher disease) to a patient with Gaucher disease once every 3 to 10 weeks, more preferably once every 4 to 8 weeks, so that the glucocerebrosidase activity is 10 to 200 U / kg of body weight. In this case, "U (unit)" refers to the unit that decomposes 1 μmol of the synthetic substrate p-nitrophenyl-β-D-glucopyranoside ("p" is italicized and "D" is small capital English letter) per minute at 37°C.

[0040] Furthermore, by containing the protein of the present invention and glucosylceramide isolated from a plant, animal, or microorganism (e.g., basidiomycete, etc.), or chemically synthesized glucosylceramide, a food composition can be provided that can easily liberate ceramide from glucosylceramide in the composition. Furthermore, by containing the protein of the present invention and the glucosylceramide as active ingredients, a food composition can be provided as a functional food in which the liberated ceramide serves as a functional ingredient, and which has one or more uses selected from improving skin moisture, preventing skin damage caused by ultraviolet rays, preventing inflammatory bowel disease, and preventing colon cancer. Furthermore, a food composition for preventing lifestyle-related diseases (e.g., diabetes, heart disease, high blood pressure, hyperlipidemia, etc.) can also be provided.

[0041] In addition, by incorporating the thermostable glucocerebrosidase of the present invention as an active ingredient, the present invention can provide a functional food, such as a food composition for preventing or treating Gaucher disease, or a food composition for supplementing ceramide, which is ingested together with a food composition containing glucosylceramide. The method of use and dosage of the food composition for preventing or treating Gaucher disease may be the same as those of the pharmaceutical composition for preventing and treating Gaucher disease described above.

[0042] Next, a method for producing ceramide using the protein of the present invention will be described in detail. The method for producing ceramide using the protein of the present invention includes a step of producing ceramide from glucosylceramide isolated from a plant, animal, or microorganism (e.g., basidiomycete) or chemically synthesized glucosylceramide using the protein of the present invention. Note that this production method may include any step other than the above as long as it does not significantly affect the effects of the present invention.

[0043] Glucosylceramide is contained in a relatively large amount in living organisms such as animals and plants compared to ceramide, and ceramide can be produced at low cost from such glucosylceramide by using the thermostable glucocerebrosidase of the present invention, which can be obtained inexpensively by mass expression using the above-mentioned transformant.Then, by using the ceramide obtained in this way, cosmetics or functional foods for the purpose of improving skin moisture, preventing skin damage caused by ultraviolet rays, and preventing colon cancer can be provided inexpensively, and further, ceramide can be provided inexpensively as a research reagent or medicine.

[0044] The above-described embodiment is merely an example for facilitating understanding of the present invention, and is not intended to limit the present invention.

[0045] Hereinafter, examples of the present invention will be described, however, the present invention is not limited to the following examples, and various modifications are possible within the technical concept of the present invention. EXAMPLES

[0046] Example 1 10 g of young leaves from rice (Oryza sativa L. cv. Nipponbare ("Oryza sativa" is in italics): Nipponbare) were collected and disrupted using a homogenizer in 50 mM acetate buffer (pH 5.5) containing 0.05% sodium cholate and 0.3% Triton X-100. The disrupted solution was centrifuged at 15,000 rpm and 4°C for 20 minutes, and the centrifuged supernatant was dialyzed against 1000 times the amount of 40 mM sodium acetate buffer (pH 5.5) containing 0.05% Tween 20 (registered trademark, the same applies below) and 0.025% sodium cholate to obtain an enzyme extract. To 50 mL of this enzyme extract, 10 mM glucosylceramide (cerebroside C, (4E,8E)-ND-2'-hydroxy-(E)-3'-octadecenoyl-1-O-β-D-glucopyranosyl-9-methyl-4,8-sphingadienine ("E", "N" and "O" are italics, "D" is small capital letters): The Journal of Antibiotics 41, (1988) 469-480, the same below) dissolved in 1 mL of ethanol and 49 mL of 0.4% sodium cholate were added and reacted at 45 ° C for 5 hours. The resulting reaction solution was adjusted to pH 11.5 with sodium carbonate solution and sodium hydroxide solution, and then ethyl acetate solution was added and mixed, and centrifuged at 3000 rpm and 4 ° C for 20 minutes. After centrifugation, the obtained ethyl acetate layer was dried and then dissolved in 80% ethanol solution and subjected to high performance liquid chromatography analysis. That is, the sample was injected into a TSKgel ODS-120T column (4.6 mm × 30 cm, manufactured by Tosoh Corporation, registered trademark (same below)), and a solvent with an ethanol concentration of 81% was passed through at a flow rate of 1.0 mL / min. The newly produced substances by the enzyme reaction were detected with a UV detector (ultraviolet absorption wavelength 215 nm) to separate them. The separated material was analyzed by IR (FTS-135, Bio-Rad) 1 H NMR, 13C NMR (Varian UNITY plus 500 spectrometer, Agilent) and ESI-MS analysis (Agilent 6460, Agilent) were performed. The results are shown in Table 1 below.

[0047] [Table 1]

[0048] From these results, it was revealed that the substance produced from cerebroside C by the above-mentioned rice-derived enzyme is a ceramide derived from cerebroside C. Furthermore, this substance was found to be the same as the ceramide produced from cerebroside C by imiglucerase (manufactured by Sanofi), a human-derived glucocerebrosidase, and the above-mentioned IR, 1 H NMR, 13 The results of C NMR and ESI-MS analyses were in perfect agreement, demonstrating that the rice-derived enzyme has glucocerebrosidase activity.

[0049] Example 2 110 g of rice stalks (Nipponbare) were collected and finely cut, then disrupted in 20 mM acetate buffer (pH 5.5) containing 0.05% sodium cholate with a homogenizer. The disrupted solution was centrifuged at 10,000 rpm and 4°C for 60 minutes, and the supernatant was removed. Further, 20 mM acetate buffer (pH 5.5) containing 0.05% sodium cholate was added to the centrifugal precipitate, and after stirring for 5 minutes, the mixture was centrifuged at 10,000 rpm and 4°C for 60 minutes, and the supernatant was removed. Then, 20 mM acetate buffer (pH 5.5) containing 0.05% sodium cholate was added to the centrifugal precipitate, and a sufficient amount of Triton X-100 was added thereto to elute glucocerebrosidase. After stirring for 30 minutes, the mixture was centrifuged at 18,000 rpm and 4°C for 60 minutes. The resulting centrifuged supernatant was filtered through a Durapore membrane filter 0.45 μm HV (Merck Millipore, registered trademark (hereinafter the same)), and then desalted and concentrated to obtain an enzyme extract.

[0050] This enzyme extract was applied to a HiTrap Q HP column (Amersham Biosciences, registered trademark (hereinafter the same)) equilibrated with 20 mM acetate buffer (pH 6.0) containing 0.05% sodium cholate and 0.1% Triton X-100. Then, the column was eluted by gradient elution from 20 mM acetate buffer (pH 6.0) containing 0.05% sodium cholate and 0.1% Triton X-100 to a buffer containing 1 M sodium chloride in 20 mM acetate buffer (pH 6.0) containing 0.05% sodium cholate and 0.1% Triton X-100. Next, fractions showing strong glucocerebrosidase activity were pooled and desalted and concentrated by ultrafiltration. This desalted concentrated solution was applied to a HiTrap SP HP column (Amersham Biosciences) equilibrated with 20 mM acetate buffer (pH 5.5) containing 0.05% sodium cholate and 0.1% Triton X-100. The solution was eluted by gradient elution from 20 mM acetate buffer (pH 5.5) containing 0.05% sodium cholate and 0.1% Triton X-100 to a buffer containing 1 M sodium chloride in 20 mM acetate buffer (pH 5.78) containing 0.05% sodium cholate and 0.1% Triton X-100, and fractionated. Enzyme fractions showing strong glucocerebrosidase activity were pooled, and the solution was desalted and concentrated by ultrafiltration to obtain rice-derived glucocerebrosidase (RGC1).

[0051] The glucocerebrosidase activity of the fraction was measured as follows. First, a predetermined amount of the sample was added to 50 mM acetate buffer (pH 5.5) containing 100 μM glucosylceramide (cerebroside B), 0.1% Tween 20, and 0.05% sodium cholate, and incubated at 37 ° C for 15 minutes. Next, 4 volumes of ethanol were added to the resulting reaction solution, mixed, centrifuged at 15,000 rpm for 20 minutes, and the centrifuged supernatant was subjected to high performance liquid chromatography analysis. For high performance liquid chromatography analysis, the sample was injected into a TSKgel ODS-120T column (4.6 mm × 30 cm), a solvent with an ethanol concentration of 83% was passed through at a flow rate of 0.8 mL / min, and the amount of ceramide newly generated by the enzyme reaction was measured by detecting with a UV detector (ultraviolet absorption wavelength 215 nm). The amount of ceramide was determined using ceramide produced from cerebroside B by imiglucerase (Sanofi), a human glucocerebrosidase, as a standard. The molecular weight of the produced ceramide was examined by negative LC-MS (Agilent) to confirm that it was produced from cerebroside B (ESI-MS m / z: 564.5 [MH] - The amount of enzyme required to produce 1 μmol of ceramide in 1 minute in the enzyme reaction solution was defined as 1 U (unit), and the glucocerebrosidase activity per mL of enzyme solution was calculated.

[0052] The protein concentration of the purified RGC1 was determined using a protein assay kit (Bio-Rad Laboratories) with bovine serum albumin as a standard and imiglucerase, the protein concentration of which had been measured in advance, as a standard. That is, the purified RGC1 solution and imiglucerase solution were injected into a TSKgel Octyl-80Ts column (4.6 mm x 15 cm, Tosoh Corporation), and run at a flow rate of 0.8 mL / min in a gradient mode of increasing the ratio of acetonitrile solution in 0.05% trifluoroacetic acid, and the peak area generated by detection with a UV detector (ultraviolet absorption wavelength 280 nm) was obtained, and the protein concentration of the purified RGC1 was determined by comparing it with imiglucerase.

[0053] The fraction containing RGC1 showed a single band in SDS-PAGE, and its average molecular weight (MW) was approximately 62 kD. SDS-PAGE was performed using AE-6000 electrophoresis (ATTO Corporation) and precast minigel e-PAGEL (E-R10L / gel concentration 10% / 18 samples, ATTO Corporation), and silver staining was performed using Silver Stain MS Kit (Wako Pure Chemical Industries, Ltd.). The molecular weight marker used was SDS-PAGE Molecular Weight Standards Low Range (Bio-Rad Laboratories).

[0054] Example 3 The RGC1 obtained in Example 2 was added to 12.5 μM glucosylceramide (any of the 12 types in Table 2 below, which are derived from animals, plants, or filamentous fungi) or synthetic β-glucoside, 50 mM acetate buffer (pH 5.5) containing 0.1% Tween 20 and 0.05% sodium cholate, and incubated at 37 ° C. for 15 minutes. Next, 4 volumes of ethanol were added to the resulting reaction solution, mixed, and centrifuged at 15,000 rpm for 20 minutes, and the amount of ceramide in the supernatant was measured using various reversed-phase columns by high-performance liquid chromatography to determine glucocerebrosidase activity. The amount of ceramide was determined using ceramide generated from the above-mentioned glucosylceramide by imiglucerase as a standard. The glucocerebrosidase activity was calculated as a relative activity when the activity using animal-derived glucosylceramide d18:1(4E)-C8:0-GluCer ("E" is in italics) as a substrate was taken as 100 (rightmost column in Table 2 below). This test was performed five times, and the average relative activity was calculated. The results are shown in Table 2 below.

[0055] [Table 2]

[0056] As a result, RGC1 hardly reacted with lactosylceramides such as d18:1(4E)-C18:0-GM3 and d18:1(4E)-C8:0-LacCer, and galactosylceramides such as d18:1(4E)-C8:0-GalCer (all "E"s are in italics), indicating that it specifically recognizes and reacts with the glucose structure of glucosylceramide. Furthermore, it hardly reacted with pNP-β-glucoside ("p" is in italics), indicating that it specifically recognizes and reacts with the ceramide structure of glucosylceramide. These results demonstrated that RGC1 is a glucocerebrosidase. It was also shown that RGC1 reacts with glucosylceramide substrates of any type derived from plants, animals, or filamentous fungi.

[0057] Example 4 There are four types of animal-derived glucocerebrosidase: glucocerebrosidase 1 (GBA1; imiglucerase, belonging to GH30), glucocerebrosidase 2 (GBA2, belonging to GH116), glucocerebrosidase 3 (GBA3, belonging to GH1), and lactase-phlorizin hydrolase (belonging to GH1). In addition, a glucocerebrosidase belonging to GH116, AtGCD3, has been isolated from Arabidopsis thaliana. Therefore, the K of RGC1 and imiglucerase obtained in Example 2 was measured using a synthetic glucosylceramide substrate, N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-glucosyl-β1-1´-sphingosine (C6-NBD glucosylceramide: “N” is in italics and “D” is in small capital letters). cat / K mThe K value (the number of substrate molecules that one enzyme molecule can convert in one second divided by the substrate concentration that gives 50% of the maximum reaction rate of the enzyme: "K" is in italics) was calculated using the Hanes-Woolf plot according to the reaction method in Example 2. In addition, the K value of GBA3, an animal-derived glucocerebrosidase, and AtGCD3, an Arabidopsis-derived glucocerebrosidase, cat / K m The values ​​were taken from the literature (Journal of Biological Chemistry 282, (2007) 30889-30900, and Journal of Biological Chemistry 295, (2020) 717-728). The results are shown in Table 3 below. From these results, RGC1 clearly has a higher K cat / K m It was revealed that this was an excellent glucocerebrosidase with high values.

[0058] [Table 3]

[0059] Example 5 The RGC1 and imiglucerase obtained in Example 2 were added to 50 mM acetate buffer (pH 5.5) containing 100 μM glucosylceramide (cerebroside B), 0.1% Tween 20 and 0.05% sodium cholate, and incubated at each temperature for 15 minutes. Next, 4 volumes of ethanol were added to the reaction solution obtained, and the mixture was centrifuged at 15000 rpm for 20 minutes. The supernatant was subjected to high performance liquid chromatography analysis to measure the amount of ceramide produced by the enzyme reaction. The high performance liquid chromatography analysis was performed in the same manner as in Example 2. The amount of ceramide and the enzyme activity were also calculated in the same manner as in Example 2. The temperature at which glucocerebrosidase activity was the highest was determined as the optimal temperature. This test was performed three times, and the average value was calculated. The results are shown in Table 4 below. These results suggest that the optimum temperature of the human glucocerebrosidase imiglucerase is 42.5°C, while the optimum temperature of the rice-derived glucocerebrosidase RGC1 is 54.0°C, which is higher than that of the human glucocerebrosidase imiglucerase, suggesting that RGC1 is highly stable in the body.

[0060] [Table 4]

[0061] Example 6 It is generally known that the higher the optimum temperature of an enzyme, the better its thermal stability. From Example 5, RGC1 has a higher optimum temperature for glucocerebrosidase activity than imiglucerase, so it is expected to have thermal stability. Therefore, the following test was carried out to confirm the thermal stability in lysosomes (pH 5) and cytoplasm (pH 7) where glucocerebrosidase mainly exists and acts in the human body. The RGC1 and imiglucerase obtained in Example 2 were incubated at 37°C for 6 to 106 hours at pH 5 (50 mM acetate buffer (pH 5.0) containing 0.1% Triton X-100 and 0.05% sodium cholate) assuming lysosomes, and at pH 7 (50 mM potassium phosphate buffer (pH 7.0) containing 0.1% Triton X-100 and 0.05% sodium cholate) assuming cytoplasm. The glucocerebrosidase activity after each incubation period was measured according to the method of Example 2. The remaining activity was calculated as a relative activity value when the activity before incubation was set to 100. This test was performed three times, and the average value was calculated. The results are shown in Figures 1 and 2. In these figures, an * is indicated when the glucocerebrosidase activity of RGC1 after each reaction time was significantly higher (1% significant) than that of imiglucerase. 1 and 2 show that RGC1 is clearly more stable and has thermal stability than imiglucerase at both pH 5 and pH 7.

[0062] Example 7 The RGC1 band obtained by SDS-PAGE in Example 2 was excised and then treated with trypsin. The molecular masses of the resulting peptide fragments were analyzed by MALDI-TOFMS (Matrix Assisted Laser Desorption / Ionization Time-of-Flight Mass Spectrometer: Microflex LRF 20, manufactured by Bruker Daltonics), and the amino acid sequences of the nine peptide fragments shown in SEQ ID NOs: 5 to 13 in the sequence listing and in FIG. 7 were determined. The precise molecular weights of these nine peptide fragments of RGC1 were in perfect agreement with those of nine peptides derived from a protein named Os3BGlu6 derived from rice (Nipponbare), whose function has not yet been identified, suggesting that RGC1 may be the same protein as Os3BGlu6. However, there have been no reports to date that Os3BGlu6 is a glucocerebrosidase.

[0063] Example 8 Total RNA was extracted from rice (Nipponbare) callus using RNeasy Plant Mini Kit (Qiagen, registered trademark (hereinafter the same)), and mRNA was purified from the total RNA using Absolutely mRNA Purification Kit (Agilent). cDNA synthesis from mRNA and subsequent RACE analysis were performed using SuperScript III Reverse Transcriptase (Thermo Fisher Scientific, registered trademark). cDNA of Os3BGlu6 was obtained by PCR amplification using SEQ ID NOs: 14 and 15 in the sequence listing and two primers (F-primer (RGC1-CN) and R-primer (RGC1-CC)) shown in Figure 8, which were prepared from the open reading frame predicted from the whole genome sequence of rice (Nipponbare). Specific PCR conditions were as follows: the rice callus cDNA and the two primers were added with KOD-Plus-Neo (Toyobo Co., Ltd.), and the reaction conditions of 94°C for 2 min, 60°C for 0.5 min, and 68°C for 1 min were repeated 35 times. The amplified fragment was subcloned into the plasmid vector pUC19. Furthermore, a longer DNA region including the outer DNA region of the amplified fragment was amplified by the same method, and the entire cDNA nucleotide sequence of the Os3BGlu6 gene was determined by analyzing the nucleotide sequence of the fragment by a standard method. This nucleotide sequence is shown in SEQ ID NO:3 and FIG. 6 in the sequence listing. The amino acid sequence translated from this nucleotide sequence is shown in SEQ ID NO:1 and FIG. 5 in the sequence listing. This amino acid sequence revealed that Os3BGlu6 belongs to GH1.

[0064] Example 9 To prove that the isolated Os3BGlu6 gene is a glucocerebrosidase gene (a gene encoding RGC1), we examined whether Os3BGlu6 produced in E. coli had glucocerebrosidase activity. E. coli (DH5α) was transformed by introducing pUC19, into which the Os3BGlu6 gene obtained in Example 8 had been subcloned. The transformant was then cultured in LB liquid medium (1.0% tryptone, 0.5% yeast extract, 1.0% sodium chloride, 50 μg / mL ampicillin) at 37° C. for 24 hours, and centrifuged at 15,000 rpm for 10 minutes to collect the cells. The resulting cells were washed twice with 50 mM acetate buffer (pH 6.0) containing 0.05% sodium cholate. Then, the cells were collected by centrifugation at 15000 rpm for 10 minutes, suspended in 50 mM acetate buffer (pH 6.0) containing 0.3% Triton X-100 and 0.05% sodium cholate, and then ultrasonically disrupted. The ultrasonically disrupted solution was centrifuged at 18000 rpm and 4°C for 60 minutes. The centrifuged supernatant was then filtered through a Durapore membrane filter 0.45 μm HV (Merck Millipore), desalted, and concentrated to obtain an enzyme extract. This enzyme extract was added to 50 mM sodium acetate buffer (pH 5.5) containing 100 μM glucosylceramide (cerebroside C), 0.1% Tween 20, and 0.05% sodium cholate, and incubated at 37°C for 13 minutes. Next, 4 volumes of ethanol were added to the reaction solution obtained, and the mixture was mixed, followed by centrifugation at 15,000 rpm for 20 minutes. The supernatant was subjected to high performance liquid chromatography analysis to measure the amount of ceramide produced by the enzyme reaction. The high performance liquid chromatography analysis was carried out in the same manner as in Example 1. The molecular weight of the produced ceramide was examined by negative LC-MS (Agilent), confirming that it was ceramide produced from cerebroside C (ESI-MS m / z: 590.5 [MH] - ) The amount of enzyme required to produce 1 μmol of ceramide in 1 minute in the enzyme reaction solution was defined as 1 U (unit), and the glucocerebrosidase activity per mL of the enzyme extract was calculated. The results are shown in Table 5 below.

[0065] [Table 5]

[0066] These results clearly demonstrated that the enzyme extract obtained from E. coli transformed with the Os3BGlu6 gene had glucocerebrosidase activity. This indicates that the isolated RGC1 is Os3BGlu6 and is a glucocerebrosidase belonging to GH1. There have been no reports to date of the discovery of a glucocerebrosidase belonging to GH1 in plants.

[0067] Example 10 The identity of the amino acid sequence of RGC1 with animal glucocerebrosidase and glucocerebrosidase AtGCD3 from Arabidopsis was examined using the EMBOSS Needle (https: / / www.ebi.ac.uk / Tools / psa / emboss_needle / ), and the identity was 14.9% with GBA1, 10.1% with GBA2, 35.8% with GBA3, 11.3% with lactase-phlorizin hydrolase, and 3.3% with AtGCD3. These results demonstrated that RGC1 is a glucocerebrosidase that is completely different from glucocerebrosidases isolated so far, even in terms of amino acid sequence.

[0068] Example 11 102 g of soybean (Glycine max (L.) Merr. Enrei ("Glycine max" is in italics): Enrei) stems were collected and finely cut, then disrupted with a homogenizer in 20 mM acetate buffer (pH 5.5) containing 0.01% sodium cholate. The disrupted solution was centrifuged at 10,000 rpm and 4°C for 60 minutes, and the supernatant was removed. Further, 20 mM acetate buffer (pH 5.5) containing 0.01% sodium cholate was added to the centrifugal precipitate, stirred for 5 minutes, and centrifuged at 10,000 rpm and 4°C for 60 minutes, and the supernatant was removed. Then, an enzyme extract was obtained from the obtained centrifugal precipitate by the same method as in Example 2.

[0069] This enzyme extract was applied to a HiTrap Q HP column (Amersham Biosciences) equilibrated with 0.5 mM phosphate buffer (pH 6.7) containing 0.05% sodium cholate and 0.05% Triton X-100. The enzyme extract was then eluted by gradient elution from 0.5 mM phosphate buffer (pH 6.7) containing 0.05% sodium cholate and 0.05% Triton X-100 to a solution containing 1 M sodium chloride in 20 mM phosphate buffer (pH 6.7) containing 0.05% sodium cholate and 0.1% Triton X-100. Next, fractions showing strong glucocerebrosidase activity were pooled and desalted and concentrated by ultrafiltration. This desalted concentrated solution was applied to a HiTrap SP HP column (Amersham Biosciences) equilibrated with 0.5 mM acetate buffer (pH 6.0) containing 0.05% sodium cholate and 0.05% Triton X-100. The column was eluted by gradient elution from 0.5 mM acetate buffer (pH 6.0) containing 0.05% sodium cholate and 0.05% Triton X-100 to a solution containing 1 M sodium chloride in 0.5 mM acetate buffer (pH 6.0) containing 0.05% sodium cholate and 0.05% Triton X-100, and fractionated. As a result, fractions showing strong glucocerebrosidase activity were pooled, and the enzyme solution was desalted and concentrated by ultrafiltration to obtain soybean-derived glucocerebrosidase (SGC1).

[0070] The glucocerebrosidase activity of the fraction and the protein concentration of SGC1 were analyzed by the same method as in Example 2. This SGC1 fraction showed a single band in SDS-PAGE, and its average molecular weight (MW) was about 62.0 kD. SDS-PAGE was also performed by the same method as in Example 2.

[0071] Example 12 The optimum temperatures for the glucocerebrosidase activity of SGC1 and imiglucerase obtained in Example 11 were confirmed by the same method as in Example 5. The results are shown in Table 6 below. These results suggest that SGC1 may be highly stable in vivo, since the optimum temperature for imiglucerase was 42.5°C while that for SGC1 was 64.0°C, which is much higher than the optimum temperature for imiglucerase.

[0072] [Table 6]

[0073] (Example 13) As mentioned above, it is known that the higher the optimum temperature of an enzyme, the better its thermal stability. From Example 12, SGC1 has a higher optimum temperature for glucocerebrosidase activity than imiglucerase, so it was expected to have thermal stability. Therefore, the following test was carried out to confirm the thermal stability in lysosomes (pH 5) and cytoplasm (pH 7). The two glucocerebrosidases, SGC1 and imiglucerase, obtained in Example 11, were incubated at 45°C for 1 to 31 hours at pH 5 (50 mM acetate buffer (pH 5.0) containing 0.1% Triton X-100 and 0.05% sodium cholate) assuming lysosomes, and at pH 7 (50 mM potassium phosphate buffer (pH 7.0) containing 0.1% Triton X-100 and 0.05% sodium cholate) assuming cytoplasm, for 0.3 to 5 hours. The glucocerebrosidase activity after each reaction time was measured according to the method of Example 2. The remaining activity was calculated as a relative activity value when the activity before incubation was set to 100. This test was performed three times, and the average value was calculated. The results are shown in Figures 3 and 4. In these figures, an * is indicated when the glucocerebrosidase activity of SGC1 after each reaction time was significantly higher (1% significant) than that of imiglucerase. 3 and 4 show that SGC1 is clearly much more stable and thermostable than imiglucerase at both pH 5 and pH 7.

[0074] Example 14 The SGC1 band obtained by SDS-PAGE in Example 11 was excised and then treated with trypsin. The molecular masses of the resulting peptide fragments were analyzed by MALDI-TOFMS (Matrix Assisted Laser Desorption / Ionization Time-of-Flight Mass Spectrometer: Microflex LRF 20, manufactured by Bruker Daltonics), and the amino acid sequences of the seven peptide fragments shown in SEQ ID NOs: 16 to 22 in the sequence listing and FIG. 11 were determined. The precise molecular weights of these seven peptide fragments derived from SGC1 were completely identical to those of the seven peptides derived from a protein named β-glucosidase 40 derived from a US soybean variety (Glycine max (L.) Merr. Williams 82 ("Glycine max" in italics)) whose function has not yet been identified, suggesting the possibility that SGC1 may be the same protein as β-glucosidase 40. Note that this β-glucosidase 40 was simply named based on a homology search with the genome sequence, and the enzyme activity of β-glucosidase has not been confirmed, let alone that it is glucocerebrosidase.

[0075] Example 15 Total RNA was extracted from soybean leaves using RNeasy Plant Mini Kit (Qiagen), and cDNA was synthesized from this total RNA using PrimeScript II 1st strand cDNA Synthesis Kit (Takara). cDNA of soybean (Enrei)-derived β-glucosidase 40 was obtained by PCR amplification using SEQ ID NOs: 23 and 24 in the sequence listing and two primers (F-primer (SGC1-CN) and R-primer (SGC1-CC)) shown in FIG. 12, which were prepared from the open reading frame predicted from the whole genome sequence of the American variety soybean (Williams 82). Specific PCR conditions were as follows: cDNA from soybean leaves and the above two primers were added with KOD-Plus-Neo (manufactured by Toyobo Co., Ltd.), and the reaction conditions of 94°C for 2 minutes, 60°C for 0.5 minutes, and 68°C for 1 minute were repeated 40 times to amplify the fragment. The amplified fragment was then subcloned into the plasmid vector pUC19. Furthermore, a longer DNA region including the outer DNA region of the amplified fragment was amplified in a similar manner, and the base sequence of the fragment was analyzed by a standard method to determine the entire cDNA base sequence of the soybean-derived β-glucosidase 40 gene. This base sequence is shown in SEQ ID NO: 4 and FIG. 10 of the sequence listing. The amino acid sequence translated from this base sequence is shown in SEQ ID NO: 2 and FIG. 9 of the sequence listing. This amino acid sequence revealed that soybean-derived β-glucosidase 40 belongs to GH1.

[0076] (Example 16) In order to prove that the soybean (Enrei)-derived β-glucosidase 40 gene is a glucocerebrosidase gene, it was examined whether the soybean-derived β-glucosidase 40 gene produced in E. coli had glucocerebrosidase activity. The soybean-derived β-glucosidase 40 gene obtained in Example 15 was subcloned into pUC19, which was then introduced into E. coli (DH5α) to transform the gene. The glucocerebrosidase activity per mL of the enzyme extract was calculated using this transformant in the same manner as in Example 9, except that the enzyme reaction was incubated at 60°C for 30 minutes. The results are shown in Table 7 below.

[0077] [Table 7]

[0078] These results clearly demonstrated that the enzyme extract obtained from E. coli transformed with the soybean-derived β-glucosidase 40 gene had glucocerebrosidase activity. This demonstrated that the isolated soybean-derived SGC1 was soybean-derived β-glucosidase 40 and a glucocerebrosidase belonging to GH1. As mentioned above, there have been no reports to date of the discovery of a glucocerebrosidase belonging to GH1 in plants.

[0079] (Example 17) The identity of the amino acid sequence of SGC1 with animal glucocerebrosidase and glucocerebrosidase AtGCD3 from Arabidopsis thaliana was examined using the EMBOSS Needle described above, and the identity was 14.9% with GBA1, 10.0% with GBA2, 35.9% with GBA3, 10.4% with lactase-phlorizin hydrolase, and 7.6% with AtGCD3. These results demonstrated that SGC1 is a glucocerebrosidase that is completely different from glucocerebrosidases isolated so far, even in terms of its amino acid sequence.

[0080] (Example 18) Using BLASTp search (https: / / blast.ncbi.nlm.nih.gov / Blast.cgi), we searched for proteins with high homology to the amino acid sequence of RGC1, and found that there are a wide variety of highly homologous proteins in seed plants. The identity was examined using the EMBOSS Needle described above. The results are shown in Table 8 below.

[0081] [Table 8]

[0082] From Table 8, the amino acid sequence of RGC1 showed 73.8-84.9% homology with β-glucosidase 6 and β-glucosidase 34 derived from monocotyledonous plants, and 62.6-70.0% homology with β-glucosidase 6, β-glucosidase 40 and β-glucosidase 34 derived from dicotyledonous plants. It also showed 46.6-53.2% homology with β-glucosidase 6 and β-glucosidase 40 from ferns and mosses. Furthermore, all of these amino acid sequences had a conserved region required for GH1 and belonged to GH1. From these results, it was considered that the above β-glucosidase 6, β-glucosidase 40 and β-glucosidase 34 were glucocerebrosidases.

[0083] (Example 19) The following test was carried out to investigate whether plants other than rice have glucocerebrosidase activity. 0.01-1 g of each part of the leaves, roots, stems, petals, pistils, pollen, fruit, rhizoids, and sporangia of various plants were collected and disrupted with a homogenizer in 50 mM acetate buffer (pH 5.0) containing 0.05% sodium cholate and 0.3% Triton X-100. The disrupted solution was centrifuged at 15,000 rpm and 4°C for 20 minutes, and the supernatant was used as the enzyme extract. The enzyme extract was incubated at 45°C for 60 minutes in 50 mM acetate buffer (pH 5.0) containing 100μM glucosylceramide (cerebroside B), 0.05% sodium cholate and 0.2% Triton X-100. Next, 4 volumes of ethanol were added to the reaction solution obtained, and the mixture was centrifuged at 15000 rpm for 20 minutes. The supernatant was subjected to high performance liquid chromatography analysis to measure the amount of ceramide produced by the enzyme reaction. The high performance liquid chromatography analysis was carried out in the same manner as in Example 2. The amount of ceramide and the enzyme activity were also calculated in the same manner as in Example 2, and the number of units of glucocerebrosidase activity per 1g of plant fresh weight was calculated. This test was carried out three times, and the average value was calculated. The results are shown in Table 9 below.

[0084] [Table 9]

[0085] From these results, glucocerebrosidase activity was confirmed in the extracts of all plants measured. Considering the results of Tables 8 and 9, it was shown that glucocerebrosidase is present not only in rice and soybean but also in plants in general. It was shown that RGC1 derived from monocotyledonous plants and SGC1 derived from dicotyledonous plants are glucocerebrosidases belonging to GH1 (Examples 9 and 16), that enzymes belonging to GH1 highly homologous to the amino acid sequence of RGC1 are present in many seed plants (Example 18), and that high glucocerebrosidase activity was detected in extracts of many seed plants as shown in Table 9 above, indicating that seed plants have glucocerebrosidases belonging to GH1. Furthermore, the presence of β-glucosidase 6 and β-glucosidase 40 in ferns and mosses (Table 8 above) and the detection of glucocerebrosidase activity in extracts of ferns and mosses sufficiently suggest that ferns and mosses also have glucocerebrosidases belonging to GH1. Considering the homology, the amino acid sequence homology between RGC1 derived from monocotyledonous plants and SGC1 derived from dicotyledonous plants, which have been proven to be glucocerebrosidase belonging to GH1 in Examples 9 and 16, is 67.6%, so an enzyme having at least 67.5% or more homology with the amino acid sequence of RGC1 and SGC1 is considered to be glucocerebrosidase belonging to GH1. Furthermore, since it has been found from Table 9 above that seed plants have glucocerebrosidase, it is considered that at least the enzyme having the lowest homology of 62.6% or more (Rosa chinensis) with the amino acid sequence of RGC1 in seed plants shown in Table 8 above is also glucocerebrosidase belonging to GH1.

[0086] (Example 20) The enzyme extracts from various plants extracted according to Example 19, as well as the above-mentioned purified rice-derived RGC1 and the above-mentioned purified soybean-derived SGC1 were added to 50 mM sodium acetate buffer (pH 5.5) containing 100 μM glucosylceramide (cerebroside B), 0.1% Tween 20 and 0.05% sodium cholate, and incubated at each temperature for 15 minutes. Next, 4 volumes of ethanol were added to the resulting reaction solution, mixed, centrifuged at 15000 rpm for 20 minutes, and the supernatant was subjected to high performance liquid chromatography analysis to measure the amount of ceramide produced by the enzyme reaction. The high performance liquid chromatography analysis was performed in the same manner as in Example 5. The amount of ceramide and the enzyme activity were also calculated in the same manner as in Example 5. As a result, the temperature with the highest glucocerebrosidase activity was determined as the optimal temperature. This test was performed three times, and the average value was calculated. The results are shown in Table 10 below.

[0087] [Table 10]

[0088] From these results, it was found that glucocerebrosidase derived from many seed plants including rice and soybean has a higher optimum temperature than the human glucocerebrosidase, imiglacerase. As shown in Examples 6 and 13, it is generally known that the higher the optimum temperature of an enzyme, the better its thermal stability. Therefore, it can be said that glucocerebrosidase belonging to GH1 derived from seed plants has a higher thermal stability than the human glucocerebrosidase, imiglacerase, i.e., it has thermal stability.

Claims

1. A pharmaceutical composition for preventing and treating Gaucher disease, comprising as an active ingredient a protein shown in (A) or (B) below. (A) A protein consisting of the amino acid sequence shown in SEQ ID NO:1, amino acid numbers 38 to 521 of SEQ ID NO:1, SEQ ID NO:2, or amino acid numbers 19 to 503 of SEQ ID NO:2 in the sequence listing. (B) A protein consisting of an amino acid sequence in which 1 to 10 amino acids have been substituted, deleted, inserted, or added in the amino acid sequence shown in SEQ ID NO: 1, amino acid numbers 38 to 521 of SEQ ID NO: 1, SEQ ID NO: 2, or amino acid numbers 19 to 503 of SEQ ID NO: 2 in the sequence listing, which belongs to glycoside hydrolase family 1 and has glucocerebrosidase activity and thermal stability.

2. A food composition containing as active ingredients the protein shown in (A) or (B) below and glucosylceramide isolated from a plant, animal, or microorganism, or chemically synthesized glucosylceramide, for one or more uses selected from improving skin moisture, preventing skin damage caused by ultraviolet rays, preventing inflammatory bowel disease, and preventing colon cancer. (A) A protein consisting of the amino acid sequence shown in SEQ ID NO:1, amino acid numbers 38 to 521 of SEQ ID NO:1, SEQ ID NO:2, or amino acid numbers 19 to 503 of SEQ ID NO:2 in the sequence listing. (B) A protein consisting of an amino acid sequence in which 1 to 10 amino acids have been substituted, deleted, inserted, or added in the amino acid sequence shown in SEQ ID NO: 1, amino acid numbers 38 to 521 of SEQ ID NO: 1, SEQ ID NO: 2, or amino acid numbers 19 to 503 of SEQ ID NO: 2 in the sequence listing, which belongs to glycoside hydrolase family 1 and has glucocerebrosidase activity and thermal stability.

Citation Information

Patent Citations

  • Production of high-mannose proteins in plant culture

    JP2006524506A

  • Vectors for conditionally expressing therapeutic proteins, host cells containing said vectors, and their use

    JP2013527753A